moxifloxacin has been researched along with Urinary Tract Infections in 10 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (20.00) | 29.6817 |
2010's | 6 (60.00) | 24.3611 |
2020's | 2 (20.00) | 2.80 |
Authors | Studies |
---|---|
Bykov, K; Fischer, MA; Gagne, JJ; Kattinakere-Sreedhara, S; Wang, J | 1 |
Benedetto, CD; Bernasconi, E; Bongiovanni, M; Colombo, G; Lucchini, GM; Piccinini, D | 1 |
Ji, S; Wang, N; Yang, W; Zhang, Y; Zhao, X; Zhu, L | 1 |
Kaur, S; Sharma, P | 1 |
Basile, V; Capone, D; Carrano, R; Federico, S; Kadilli, I; Nappi, R; Polichetti, G; Sabbatini, M; Tarantino, G | 1 |
Cui, X; Li, Y; Qiao, L | 1 |
Clerk, A; Karnad, DR; Pandit, R; Raodeo, A; Sanjith, S | 1 |
Malithong, A; Phiboonbanakit, D; Santiwatanakul, S; Srisangchan, P; Srisurat, N; Susaengrat, W; Tantisiriwat, W; Thamlikitkul, V; Thunyaharn, S; Tiengrim, S | 1 |
Denizbasi, A; Erdede, M; Guneysel, O; Onur, O | 1 |
Hollauer, K; Kirchbauer, D; Naber, KG; Witte, W | 1 |
2 trial(s) available for moxifloxacin and Urinary Tract Infections
Article | Year |
---|---|
Population pharmacokinetics of intravenous moxifloxacin 400 mg once-daily dosage in infected patients.
Topics: Administration, Intravenous; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Female; Fluoroquinolones; Gastrointestinal Diseases; Humans; Male; Middle Aged; Models, Theoretical; Moxifloxacin; Nonlinear Dynamics; Prospective Studies; Respiratory Tract Infections; Urinary Tract Infections; Young Adult | 2014 |
Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients.
Topics: Administration, Oral; Adult; Anti-Infective Agents; Aza Compounds; Cyclosporine; Female; Fluoroquinolones; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Humans; Immunosuppressive Agents; Kidney Transplantation; Male; Middle Aged; Moxifloxacin; Quinolines; Tacrolimus; Time Factors; Urinary Tract Infections | 2010 |
8 other study(ies) available for moxifloxacin and Urinary Tract Infections
Article | Year |
---|---|
Association between initiation of fluoroquinolones and hospital admission or emergency department visit for suicidality: population based cohort study.
Topics: Adult; Anti-Bacterial Agents; Azithromycin; Ciprofloxacin; Cohort Studies; Emergency Service, Hospital; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Hospitals; Humans; Levofloxacin; Moxifloxacin; Norfloxacin; Retrospective Studies; Suicidal Ideation; Suicide; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections | 2022 |
A case of spondylodiscitis by Ureaplasma urealyticum in an immunocompetent adult with spine stabilization.
Topics: Adult; Discitis; Humans; Middle Aged; Moxifloxacin; Polymerase Chain Reaction; Ureaplasma urealyticum; Urinary Tract Infections | 2023 |
Protease-Sensitive Inhibitory Activity of Cell-free Supernatant of Lactobacillus crispatus 156 Synergizes with Ciprofloxacin, Moxifloxacin and Streptomycin Against Pseudomonas aeruginosa: An In Vitro Study.
Topics: Anti-Bacterial Agents; Chemical Phenomena; Ciprofloxacin; Culture Media, Conditioned; DNA, Bacterial; Drug Synergism; Female; Fluoroquinolones; Hot Temperature; Humans; Hydrogen-Ion Concentration; Lactobacillus; Microbial Sensitivity Tests; Moxifloxacin; Peptide Hydrolases; Pseudomonas aeruginosa; Sequence Analysis, DNA; Streptomycin; Urinary Tract Infections; Vagina | 2015 |
Status epilepticus attributed to moxifloxacin in an adolescent patient with spina bifida occulta.
Topics: Anti-Infective Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Renal Insufficiency; Spina Bifida Occulta; Status Epilepticus; Urinary Tract Infections; Young Adult | 2011 |
Moxifloxacin-induced rhabdomyolysis.
Topics: Aged; Anti-Bacterial Agents; Aza Compounds; Female; Fluoroquinolones; Humans; Moxifloxacin; Quinolines; Rhabdomyolysis; Urinary Tract Infections | 2012 |
Comparative in vitro activity of sitafloxacin against bacteria isolated from Thai patients with urinary tract infections and lower respiratory tract infections.
Topics: Anti-Bacterial Agents; Aza Compounds; Bacteria; Ciprofloxacin; Fluoroquinolones; Humans; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Ofloxacin; Quinolines; Respiratory Tract Infections; Thailand; Urinary Tract Infections | 2012 |
Trimethoprim/sulfamethoxazole resistance in urinary tract infections.
Topics: Adolescent; Adult; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Anti-Infective Agents, Urinary; Aza Compounds; Ceftriaxone; Drug Resistance, Microbial; Escherichia coli Infections; Female; Fluoroquinolones; Humans; Male; Middle Aged; Moxifloxacin; Quinolines; Retrospective Studies; Trimethoprim, Sulfamethoxazole Drug Combination; Urinary Tract Infections; Young Adult | 2009 |
In vitro activity of gatifloxacin compared with gemifloxacin, moxifloxacin, trovafloxacin, ciprofloxacin and ofloxacin against uropathogens cultured from patients with complicated urinary tract infections.
Topics: Anti-Infective Agents; Aza Compounds; Ciprofloxacin; Escherichia coli; Fluoroquinolones; Gatifloxacin; Gemifloxacin; Humans; Klebsiella; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Urinary Tract Infections | 2000 |